reported that in hypertensive rodent model, liraglutide treatment normalized blood pressure, cardiac hypertrophy, vascular fibrosis, endothelial dysfunction, oxidative stress and vascular inflammation in an endothelial GLP-1R-dependent and myeloid cell GLP-1R-independent manner28. The gene discussed is GLP1R; the disease is cardiac hypertrophy.